Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study.
Ferraro DA, Becker AS, Kranzbühler B, Mebert I, Baltensperger A, Zeimpekis KG, Grünig H, Messerli M, Rupp NJ, Rueschoff JH, Mortezavi A, Donati OF, Sapienza MT, Eberli D, Burger IA. Ferraro DA, et al. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3315-3324. doi: 10.1007/s00259-021-05261-y. Epub 2021 Feb 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33620559 Free PMC article.
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Müller J, Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Kedzia S, Eberli D, Guckenberger M, Kroeze SGC, Sulser T, Schmid DM, Omlin A, Müller A, Zilli T, John H, Kranzbuehler H, Kaufmann PA, von Schulthess GK, Burger IA. Müller J, et al. Among authors: ferraro da. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):889-900. doi: 10.1007/s00259-018-4203-0. Epub 2018 Nov 28. Eur J Nucl Med Mol Imaging. 2019. PMID: 30488099
Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
Messerli M, Kotasidis F, Burger IA, Ferraro DA, Muehlematter UJ, Weyermann C, Kenkel D, von Schulthess GK, Kaufmann PA, Huellner MW. Messerli M, et al. Among authors: ferraro da. Br J Radiol. 2019 Apr;92(1096):20180792. doi: 10.1259/bjr.20180792. Epub 2019 Feb 26. Br J Radiol. 2019. PMID: 30673302 Free PMC article.
First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands.
Rupp NJ, Umbricht CA, Pizzuto DA, Lenggenhager D, Töpfer A, Müller J, Muehlematter UJ, Ferraro DA, Messerli M, Morand GB, Huber GF, Eberli D, Schibli R, Müller C, Burger IA. Rupp NJ, et al. Among authors: ferraro da. J Nucl Med. 2019 Sep;60(9):1270-1276. doi: 10.2967/jnumed.118.222307. Epub 2019 Feb 8. J Nucl Med. 2019. PMID: 30737300 Free article.
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer.
Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Rupp NJ, Huellner M, Messerli M, Rüschoff JH, Ter Voert EEGW, Hermanns T, Burger IA. Ferraro DA, et al. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):147-159. doi: 10.1007/s00259-019-04511-4. Epub 2019 Sep 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31522272
41 results